This study is looking at whether a digital support tool can help people with Adhd. Participants receive a study treatment and complete follow-up visits and assessments.
In Salt Lake City
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This study exists to compare options and see whether the medication ITI-007 offers something meaningfully different. Researchers are trying to understand what the medication ITI-007 could change in day-to-day care and decision-making.
This study exists to compare options and see whether the medication ITI-007 offers something meaningfully different. Researchers are trying to understand what the medication ITI-007 could change in day-to-day care and decision-making.
This study exists to better understand the safety of this type of care and how manageable it feels in practice. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
In Hollywood
ADHDDrugFrom 4 Years to 12 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
In Orlando
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.